A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.

Joon Yeul NamA Reum ChoeDong Hyun SinnJeong-Hoon LeeHwi Young KimSu Jong YuYoon Jun KimJung-Hwan YoonJeong Min LeeJin Wook ChungSun Young ChoiJeong Kyong LeeSeung Yon BaekHye Ah LeeTae Hun KimKwon Yoo

Published in: BMC cancer (2020)

ASAR provides refined prognostication for repetition of TACE in patients with unresectable HCC. For Child-Pugh class B patients, a modified model with baseline factors might guide TACE initiation.

Keyphrases

risk assessment
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
mental health
peritoneal dialysis
radiofrequency ablation
heavy metals
squamous cell carcinoma
radiation therapy
decision making
human health
climate change
patient reported